{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:12:31Z","timestamp":1778728351438,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.tice.2026.103417","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:32:01Z","timestamp":1772670721000},"page":"103417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Advances in cell-based therapies for Peripheral arterial disease"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6525-5299","authenticated-orcid":false,"given":"Maisa","family":"Ribeiro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tice.2026.103417_bib1","article-title":"CRISPR\/Cas9-modified hematopoietic stem cells-present and future perspectives for stem cell transplantation","author":"Alberto","year":"2019","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.tice.2026.103417_bib2","article-title":"Regulation of cell-based therapies in Europe: current challenges and emerging issues","author":"Alessandro","year":"2013","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.tice.2026.103417_bib3","article-title":"Gene therapy for sickle cell disease","author":"Alexis","year":"2023","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.tice.2026.103417_bib4","article-title":"Patient-centred clinical trial design","author":"Allison","year":"2022","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.tice.2026.103417_bib5","doi-asserted-by":"crossref","DOI":"10.1208\/s12248-022-00692-3","article-title":"Nanotechnology-driven cell-based therapies in regenerative medicine","author":"Alzate-Correa","year":"2022","journal-title":"AAPS J."},{"key":"10.1016\/j.tice.2026.103417_bib6","article-title":"Prognosis and clinical trial design in traumatic brain injury: the IMPACT study","author":"Andrew","year":"2007","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.tice.2026.103417_bib7","article-title":"Advances in manufacturing chimeric antigen receptor immune cell therapies","author":"Apoorva","year":"2024","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.tice.2026.103417_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/sj.gt.3301142","article-title":"Stem cell therapy and gene transfer for regeneration","author":"Asahara","year":"2000","journal-title":"Gene Ther."},{"key":"10.1016\/j.tice.2026.103417_bib9","article-title":"Cost-effective, safe, and personalized cell therapy for critical limb ischemia in type 2 diabetes mellitus","author":"B\u00e1rbara","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tice.2026.103417_bib10","article-title":"Allogeneic CAR T cell therapy for cancer","author":"Barbra Johnson","year":"2023","journal-title":"Annu. Rev. Cancer Biol."},{"key":"10.1016\/j.tice.2026.103417_bib11","article-title":"The current socioeconomic and regulatory landscape of immune effector cell therapies","author":"Chiranjeevi","year":"2024","journal-title":"Front. Med."},{"key":"10.1016\/j.tice.2026.103417_bib12","article-title":"Translating mesenchymal stem cell and their exosome research into GMP compliant advanced therapy products: promises, problems and prospects","author":"Chui-Yan","year":"2023","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.tice.2026.103417_bib13","article-title":"Biomaterials as carrier, barrier and reactor for cell-based regenerative medicine","author":"Chunxiao","year":"2015","journal-title":"Protein Cell"},{"key":"10.1016\/j.tice.2026.103417_bib14","article-title":"Allogeneic double-negative CAR-T cells inhibit tumor growth without off-tumor toxicities","author":"Daniel","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.tice.2026.103417_bib15","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s41591-023-02785-8","article-title":"Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1\/2 trial","volume":"30","author":"David","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.tice.2026.103417_bib16","article-title":"Endothelial progenitor cells as molecular targets in vascular senescence and repair","author":"Divya","year":"2018","journal-title":"Curr. Stem Cell Res. amp Ther."},{"key":"10.1016\/j.tice.2026.103417_bib17","article-title":"Effectiveness of stem cell therapy for diabetic foot ulcers: cell therapy alone is not enough for effective management of chronic wounds","author":"Ekaterina","year":"2024","journal-title":"Int. J. Low. Extrem. Wounds"},{"key":"10.1016\/j.tice.2026.103417_bib18","article-title":"Circulating biomarkers of endothelial dysfunction and inflammation in predicting clinical outcomes in diabetic patients with critical limb ischemia","author":"Francesco Vieceli Dalla","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tice.2026.103417_bib19","article-title":"Therapeutic angiogenesis in critical limb ischemia","author":"Geoffrey","year":"2012","journal-title":"Angiology"},{"key":"10.1016\/j.tice.2026.103417_bib20","article-title":"Mesenchymal stem cell therapy for non-healing diabetic foot ulcer infection: new insight","author":"Golnaz","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.tice.2026.103417_bib21","article-title":"Stem cell therapy: a revolutionary cure or a pandora's box","author":"Hany","year":"2025","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.tice.2026.103417_bib22","article-title":"Pragmatic clinical trials in CKD: opportunities and challenges","author":"Ian","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.tice.2026.103417_bib23","article-title":"Sources of stem cells for regenerative medicine","author":"Jennifer","year":"2008","journal-title":"Stem Cell Rev."},{"key":"10.1016\/j.tice.2026.103417_bib24","article-title":"Safety and efficacy of placenta-derived mesenchymal stem cell treatment for diabetic patients with critical limb ischemia: a pilot study","author":"Jiao","year":"2019","journal-title":"Exp. Clin. Endocrinol. &amp Diabetes"},{"key":"10.1016\/j.tice.2026.103417_bib25","article-title":"Vascular stem\/progenitor cells in vessel injury and repair","author":"Jiaping","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.tice.2026.103417_bib26","article-title":"Stem cell sources for tooth regeneration: current status and future prospects","author":"Keishi","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.tice.2026.103417_bib27","article-title":"Allogeneic CAR cell therapy-more than a pipe dream","author":"Kenneth","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.tice.2026.103417_bib28","doi-asserted-by":"crossref","DOI":"10.1007\/s12015-022-10379-z","article-title":"Stem and somatic cell monotherapy for the treatment of diabetic foot ulcers: review of clinical studies and mechanisms of action","author":"Krasilnikova","year":"2022","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.tice.2026.103417_bib29","doi-asserted-by":"crossref","first-page":"169","DOI":"10.62347\/MZKI8393","article-title":"Fetal progenitor cells for treatment of chronic limb ischemia","volume":"13","author":"Kukharchuk","year":"2024","journal-title":"Am. J. Stem Cells"},{"key":"10.1016\/j.tice.2026.103417_bib30","article-title":"Revolutionizing CAR T-cell therapies: innovations in genetic engineering and manufacturing to enhance efficacy and accessibility","author":"Lorenzo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tice.2026.103417_bib31","article-title":"Therapeutic strategies for cell-based neovascularization in critical limb ischemia","author":"Makoto","year":"2017","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.tice.2026.103417_bib32","article-title":"Early methodological developments for clinical trials at the national heart, lung and blood institute","author":"Max","year":"1990","journal-title":"Stat. Med."},{"key":"10.1016\/j.tice.2026.103417_bib33","article-title":"Endothelial stem and progenitor cells (stem cells): (2017 Grover Conference Series)","author":"Mervin","year":"2017","journal-title":"Pulm. Circ."},{"key":"10.1016\/j.tice.2026.103417_bib34","article-title":"Regulated and unregulated clinical trials of stem cell therapies for stroke","author":"Michael","year":"2017","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.tice.2026.103417_bib35","article-title":"Addressing the manufacturing challenges of cell-based therapies","author":"Miguel De Almeida","year":"2019","journal-title":"Adv. Biochem. Eng. \/Biotechnol."},{"key":"10.1016\/j.tice.2026.103417_bib36","article-title":"Patient-, provider-, and system-level barriers to heart failure care","author":"Mindy","year":"2009","journal-title":"J. Cardiovasc. Nurs."},{"key":"10.1016\/j.tice.2026.103417_bib37","article-title":"Manufacturing cell and gene therapies: challenges in clinical translation","author":"Na Kyung","year":"2024","journal-title":"Ann. Lab. Med."},{"key":"10.1016\/j.tice.2026.103417_bib38","article-title":"Endothelial progenitor cells in health and atherosclerotic disease","author":"Nikos","year":"2007","journal-title":"Ann. Med."},{"key":"10.1016\/j.tice.2026.103417_bib39","article-title":"Adoption and use of health information technology in physician practice organisations: systematic review","author":"Rachel","year":"2010","journal-title":"Inform. Prim. care"},{"key":"10.1016\/j.tice.2026.103417_bib40","article-title":"Current state of stem cell-based therapies: an overview","author":"Riham Mohamed","year":"2020","journal-title":"Stem Cell Investig."},{"key":"10.1016\/j.tice.2026.103417_bib41","article-title":"The translation of cell-based therapies: clinical landscape and manufacturing challenges","author":"Rj","year":"2015","journal-title":"Regen. Med."},{"key":"10.1016\/j.tice.2026.103417_bib42","article-title":"Recent trends in stem cell-based therapies and applications of artificial intelligence in regenerative medicine","author":"Sayali","year":"2021","journal-title":"World J. Stem Cells"},{"key":"10.1016\/j.tice.2026.103417_bib43","article-title":"Binding of dickkopf-3 to CXCR7 enhances vascular progenitor cell migration and degradable graft regeneration","author":"Shirin Issa","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.tice.2026.103417_bib44","article-title":"The design and evaluation of hybrid controlled trials that leverage external data and randomization","author":"Steffen","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tice.2026.103417_bib45","article-title":"Optimizing clinical trial design for assessing the efficacy of functional foods","author":"Suhad","year":"2010","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.tice.2026.103417_bib46","article-title":"Tissue engineering and regenerative medicine: perspectives and challenges","author":"Van","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.tice.2026.103417_bib47","article-title":"Mesenchymal stem cells and vascular regeneration","author":"Wenduo","year":"2017","journal-title":"Microcirculation"},{"key":"10.1016\/j.tice.2026.103417_bib48","article-title":"Adipose-derived stem cells for future regenerative system medicine","author":"Yani","year":"2012","journal-title":"Indones. Biomed. J."},{"key":"10.1016\/j.tice.2026.103417_bib49","article-title":"Managing allorejection in off-the-shelf CAR-engineered cell therapies","author":"Yan-Ruide","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tice.2026.103417_bib50","article-title":"Histone deacetylase 7-derived peptides play a vital role in vascular repair and regeneration","author":"Yiwa","year":"2018","journal-title":"Adv. Sci."}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816626001096?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816626001096?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:05:52Z","timestamp":1778727952000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816626001096"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":50,"alternative-id":["S0040816626001096"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2026.103417","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in cell-based therapies for Peripheral arterial disease","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2026.103417","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103417"}}